𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Exon-intron organization of the human multidrug-resistance protein 2 (MRP2) gene mutated in Dubin–Johnson syndrome

✍ Scribed by Hiroyuki Tsujii*; Jörg König*; Daniel Rost*; Birgit Stöckel*; Ulrich Leuschner‡; Dietrich Keppler*


Book ID
118522052
Publisher
Elsevier Science
Year
1999
Tongue
English
Weight
450 KB
Volume
117
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Expression of the multidrug resistance p
✍ Anne T. Nies; Jörg König; Marion Pfannschmidt; Ernst Klar; Walter J. Hofmann; Di 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 1000 KB

Treatment of hepatocellular carcinoma (HCC) by chemotherapy is often impeded by the intrinsic multidrug resistance (MDR) of this frequent primary cancer of the liver. The MDR phenotype can be caused by ATP-dependent export of chemotherapeutic drugs across the plasma membrane being mediated by transp

The human multidrug resistance protein 2
✍ Toshiya Tanaka; Takeshi Uchiumi; Eiji Hinoshita; Akihiko Inokuchi; Satoshi Toh; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB

The human multidrug resistance protein 2 (MRP2), also termed as the canalicular multispecific organic anion transporter (cMOAT), is a member of the adenosine triphosphatebinding cassette transporter superfamily. In the liver, MRP2 mediates the multispecific efflux of various types of organic anions,